| Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase JT Garrett, MG Olivares, C Rinehart, ND Granja-Ingram, V Sánchez, ... Proceedings of the National Academy of Sciences 108 (12), 5021-5026, 2011 | 515 | 2011 |
| Epithelial-mesenchymal transition, cancer stem cells and treatment resistance B Dave, V Mittal, NM Tan, JC Chang Breast Cancer Research 14, 1-5, 2012 | 307 | 2012 |
| Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2 … B Dave, I Migliaccio, MC Gutierrez, MF Wu, GC Chamness, H Wong, ... Journal of clinical oncology 29 (2), 166, 2011 | 288 | 2011 |
| Three-Dimensional In Vitro Co-Culture Model of Breast Tumor using Magnetic Levitation H Jaganathan, J Gage, F Leonard, S Srinivasan, GR Souza, B Dave, ... Scientific reports 4 (1), 6468, 2014 | 231 | 2014 |
| Modulation of the hepatitis C virus RNA-dependent RNA polymerase activity by the non-structural (NS) 3 helicase and the NS4B membrane protein S Piccininni, A Varaklioti, M Nardelli, B Dave, KD Raney, JEG McCarthy Journal of Biological Chemistry 277 (47), 45670-45679, 2002 | 225 | 2002 |
| Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer S Granados-Principal, Y Liu, ML Guevara, E Blanco, DS Choi, W Qian, ... Breast cancer research 17, 1-16, 2015 | 224 | 2015 |
| Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer U Bharadwaj, TK Eckols, M Kolosov, MM Kasembeli, A Adam, D Torres, ... Oncogene 34 (11), 1341-1353, 2015 | 163 | 2015 |
| Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition BN Rexer, AJL Ham, C Rinehart, S Hill, N de Matos Granja-Ingram, ... Oncogene 30 (40), 4163-4174, 2011 | 155 | 2011 |
| Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitors A Chakrabarty, NE Bhola, C Sutton, R Ghosh, MG Kuba, B Dave, ... Cancer research 73 (3), 1190-1200, 2013 | 133 | 2013 |
| The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN B Dave, RR Eason, SR Till, Y Geng, MC Velarde, TM Badger, ... Carcinogenesis 26 (10), 1793-1803, 2005 | 131 | 2005 |
| Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1 DS Choi, E Blanco, YS Kim, AA Rodriguez, H Zhao, THM Huang, ... Stem cells 32 (9), 2309-2323, 2014 | 123 | 2014 |
| Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling B Dave, S Granados-Principal, R Zhu, S Benz, S Rabizadeh, ... Proceedings of the National Academy of Sciences 111 (24), 8838-8843, 2014 | 119 | 2014 |
| Treatment resistance in stem cells and breast cancer B Dave, J Chang Journal of mammary gland biology and neoplasia 14, 79-82, 2009 | 111 | 2009 |
| Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway JS Crabtree, SA Jelinsky, HA Harris, SE Choe, MM Cotreau, ... Cancer research 69 (15), 6171-6178, 2009 | 108 | 2009 |
| Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models RR Rosato, D Dávila-González, DS Choi, W Qian, W Chen, AJ Kozielski, ... Breast Cancer Research 20, 1-16, 2018 | 86 | 2018 |
| DNA repair signature is associated with anthracycline response in triple negative breast cancer patients AA Rodriguez, A Makris, MF Wu, M Rimawi, A Froehlich, B Dave, ... Breast cancer research and treatment 123, 189-196, 2010 | 86 | 2010 |
| Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma KH Lu, W Wu, B Dave, BM Slomovitz, TW Burke, MF Munsell, ... Clinical Cancer Research 14 (9), 2543-2550, 2008 | 86 | 2008 |
| Selective small molecule Stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft model B Dave, MD Landis, LE Dobrolecki, MF Wu, X Zhang, TF Westbrook, ... Public Library of Science 7 (8), e30207, 2012 | 80 | 2012 |
| Comparison of patients' needs and doctors' perceptions of information requirements related to a diagnosis of oesophageal or gastric cancer E Wittmann, C Beaton, WG Lewis, AN Hopper, F Zamawi, C Jackson, ... European journal of cancer care 20 (2), 187-195, 2011 | 70 | 2011 |
| Role of RPL39 in metaplastic breast cancer B Dave, DD Gonzalez, ZB Liu, X Li, H Wong, S Granados, NE Ezzedine, ... JNCI: Journal of the National Cancer Institute 109 (6), djw292, 2017 | 66 | 2017 |
